Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
Current Diabetes Reports
Metadata
Title
Gut peptides and type 2 diabetes mellitus treatment
Author
Bo Ahrén, MD, PhD
Publication date
01-10-2003
Publisher
Current Medicine Group
Published in
Current Diabetes Reports / Issue 5/2003
Print ISSN: 1534-4827
Electronic ISSN: 1539-0829
DOI
https://doi.org/10.1007/s11892-003-0079-9

Other articles of this Issue 5/2003

Current Diabetes Reports 5/2003 Go to the issue

OriginalPaper

Insulin therapy for type 2 diabetes

OriginalPaper

Medications or lifestyle change with medical nutrition therapy

Clinical Trials Report

Reducing CVD risk in type 2 DM

OriginalPaper

Nutrition therapy for diabetic nephropathy

News

Literature alert

OriginalPaper

Nutrition therapy for diabetic gastroparesis

ACC 2024 Congress Coverage

Heart Failure Video

Year in Review: Heart failure and cardiomyopathies

Watch now

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits